Newsroom

Recent News Releases

June 29, 2017 Jun 29, 2017 Takeda Submits a New Drug Application for Rasagiline Mesylate for the Treatment of Parkinson’s Disease in Japan

June 27, 2017 Jun 27, 2017 Takeda Announces New Assignments of Directors

June 26, 2017 Jun 26, 2017 Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS^® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

June 26, 2017 Jun 26, 2017 Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines for Low- and Middle-Income Countries around the Globe

June 23, 2017 Jun 23, 2017 Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

SEE ALL NEWS AND RELEASES >

Featured Topics

Inflammatory Bowel Disease (IBD) Patient Engagement in R&D
LEARN MORE

Digital Innovation for Better Disease Management in Inflammatory Bowel Disease (IBD)
LEARN MORE

FOR MORE TOPICS>

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.